Provided by Tiger Fintech (Singapore) Pte. Ltd.

X4 Pharmaceuticals Inc

4.30
+0.600016.22%
Post-market: 4.300.00000.00%19:45 EDT
Volume:265.23K
Turnover:1.12M
Market Cap:24.89M
PE:1.99
High:4.35
Open:3.83
Low:3.83
Close:3.70
Loading ...
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2023

Correspondence

Form CORRESP - Correspondence
Jun 16, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 27, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 16, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]